These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 23608005

  • 1. [Primary failure of measles vaccine in a ten-year-old boy].
    Toft Kristensen MA.
    Ugeskr Laeger; 2013 Feb 25; 175(9):567-8. PubMed ID: 23608005
    [Abstract] [Full Text] [Related]

  • 2. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M, Broder KR, Temte JL, Snider DE, Seward JF, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2010 May 07; 59(RR-3):1-12. PubMed ID: 20448530
    [Abstract] [Full Text] [Related]

  • 3. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine administration of the second dose of measles-mumps-rubella vaccine.
    American Academy of Pediatrics. Committee on Infectious Diseases.
    Pediatrics; 1998 Jan 07; 101(1 Pt 1):129-33. PubMed ID: 11345975
    [Abstract] [Full Text] [Related]

  • 4. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2013 Jun 14; 62(RR-04):1-34. PubMed ID: 23760231
    [Abstract] [Full Text] [Related]

  • 5. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G, Rasidah N, Wan S, Cutter J.
    Singapore Med J; 2007 Jul 14; 48(7):656-61. PubMed ID: 17609829
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
    Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H.
    J Trop Pediatr; 2011 Oct 14; 57(5):347-51. PubMed ID: 21078605
    [Abstract] [Full Text] [Related]

  • 9. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 Oct 14; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 10. MMR vaccine effectiveness in an outbreak that involved day-care and primary schools.
    Barrabeig I, Rovira A, Muñoz P, Batalla J, Rius C, Sánchez JA, Domínguez À.
    Vaccine; 2011 Oct 19; 29(45):8024-31. PubMed ID: 21893145
    [Abstract] [Full Text] [Related]

  • 11. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2006 Jan 19; 27(1):63-9. PubMed ID: 16432596
    [Abstract] [Full Text] [Related]

  • 12. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children.
    He H, Chen E, Chen H, Wang Z, Li Q, Yan R, Guo J, Zhou Y, Pan J, Xie S.
    Vaccine; 2014 Jun 30; 32(31):4001-5. PubMed ID: 24837773
    [Abstract] [Full Text] [Related]

  • 13. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [Abstract] [Full Text] [Related]

  • 14. Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles.
    Morgan OW, Meltzer M, Muir D, Hogan H, Seng C, Hill J, Beckford J.
    Commun Dis Public Health; 2003 Dec 01; 6(4):330-3. PubMed ID: 15067861
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
    Sørup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H.
    JAMA; 2014 Feb 26; 311(8):826-35. PubMed ID: 24570246
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM.
    J Infect Dis; 2004 Jul 01; 190(1):83-90. PubMed ID: 15195246
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.